Related Experiment Video
Updated: Jul 16, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Tiotropium and simplified detection of dynamic hyperinflation
Arthur F Gelb1, Colleen Flynn Taylor2, Patricia A McClean3
1Geffen School of Medicine at UCLA, Los Angeles, CA.
Tiotropium did not reduce metronome-paced hyperventilation-induced dynamic hyperinflation in COPD patients. However, it improved baseline inspiratory capacity, potentially masking the effects of dynamic hyperinflation.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Dynamic hyperinflation (DH) is a key feature in moderate-to-severe COPD.
- Metronome-paced hyperventilation (MPH) is a method to detect DH by measuring inspiratory capacity (IC) reduction.
Purpose of the Study:
- To evaluate the effect of tiotropium on MPH-induced DH in COPD patients.
- To assess if tiotropium treatment alters the detection of DH using IC reduction during MPH.
Main Methods:
- Sixty patients with moderate-to-severe COPD underwent MPH before and after 30 days of tiotropium treatment.
- Inspiratory capacity (IC) and FEV1 were measured before and after MPH.
- Patients maintained a constant tidal volume during MPH.
Main Results:
- Tiotropium treatment increased baseline IC and FEV1.
- MPH consistently induced DH, characterized by decreased IC and increased end-expiratory lung volume (EELV).
- Tiotropium did not significantly alter the magnitude of MPH-induced DH or IC reduction compared to baseline.
Conclusions:
- Tiotropium does not reduce MPH-induced dynamic hyperinflation in COPD patients.
- Bronchodilation from tiotropium may lead to lower baseline lung volumes, potentially blunting the observable effects of MPH-induced DH.
- MPH remains a simple and clinically useful method for screening and monitoring changes in IC related to COPD treatments.
More Related Videos
Related Concept Videos
Cholinergic Antagonists: Pharmacokinetics
Inhaled Medications
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
COPD: Management Using Bronchodilators and Corticosteroids
Measurement of Blood Pressure
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...

